90 related articles for article (PubMed ID: 2783140)
1. Synergistic interaction between 13-cis-retinoic acid and glucarate: activity against rat mammary tumor induction and MCF-7 cells.
Abou-Issa H; Koolemans-Beynen A; Minton JP; Webb TE
Biochem Biophys Res Commun; 1989 Sep; 163(3):1364-9. PubMed ID: 2783140
[TBL] [Abstract][Full Text] [Related]
2. Putative metabolites derived from dietary combinations of calcium glucarate and N-(4-hydroxyphenyl)retinamide act synergistically to inhibit the induction of rat mammary tumors by 7,12-dimethylbenz[a]anthracene.
Abou-Issa HM; Duruibe VA; Minton JP; Larroya S; Dwivedi C; Webb TE
Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4181-4. PubMed ID: 2967969
[TBL] [Abstract][Full Text] [Related]
3. Dietary glucarate as anti-promoter of 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis.
Walaszek Z; Hanausek-Walaszek M; Minton JP; Webb TE
Carcinogenesis; 1986 Sep; 7(9):1463-6. PubMed ID: 3091283
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of growth inhibition of mammary carcinomas by glucarate and the glucarate: retinoid combination.
Webb TE; Abou-Issa H; Stromberg PC; Curley RC; Nguyen MH
Anticancer Res; 1993; 13(6A):2095-9. PubMed ID: 8297119
[TBL] [Abstract][Full Text] [Related]
5. Basis for the anti-tumor and chemopreventive activities of glucarate and the glucarate:retinoid combination.
Abou-Issa H; Dwivedi C; Curley RW; Kirkpatrick R; Koolemans-Beynen A; Engineer FN; Humphries KA; el-Masry W; Webb TE
Anticancer Res; 1993; 13(2):395-9. PubMed ID: 8517653
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics relevant to the anti-carcinogenic and anti-tumor activities of glucarate and the synergistic combination of glucarate:retinoid in the rat.
Webb TE; Pham-Nguyen MH; Darby M; Hamme AT
Biochem Pharmacol; 1994 Apr; 47(9):1655-60. PubMed ID: 8185680
[TBL] [Abstract][Full Text] [Related]
7. Antitumour synergism between non-toxic dietary combinations of isotretinoin and glucarate.
Abou-Issa H; Koolemans-Beynen A; Meredith TA; Webb TE
Eur J Cancer; 1992; 28A(4-5):784-8. PubMed ID: 1388036
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative effect of dietary glucarate on the Sprague-Dawley rat mammary gland.
Walaszek Z; Hanausek M; Sherman U; Adams AK
Cancer Lett; 1990 Jan; 49(1):51-7. PubMed ID: 2302696
[TBL] [Abstract][Full Text] [Related]
9. Activity of D-glucarate analogues: synergistic antiproliferative effects with retinoid in cultured human mammary tumor cells appear to specifically require the D-glucarate structure.
Curley RW; Humphries KA; Koolemans-Beynan A; Abou-Issa H; Webb TE
Life Sci; 1994; 54(18):1299-303. PubMed ID: 8190001
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapeutic evaluation of glucarate and N-(4-hydroxyphenyl)retinamide alone and in combination in the rat mammary tumor model.
Abou-Issa H; Webb TE; Minton JP; Moeschberger M
J Natl Cancer Inst; 1989 Dec; 81(23):1820-3. PubMed ID: 2531231
[TBL] [Abstract][Full Text] [Related]
11. Tumor prevention by 9-cis-retinoic acid in the N-nitroso-N-methylurea model of mammary carcinogenesis is potentiated by the pineal hormone melatonin.
Nowfar S; Teplitzky SR; Melancon K; Kiefer TL; Cheng Q; Dwived PD; Bischoff ED; Moro K; Anderson MB; Dai J; Lai L; Yuan L; Hill SM
Breast Cancer Res Treat; 2002 Mar; 72(1):33-43. PubMed ID: 12004806
[TBL] [Abstract][Full Text] [Related]
12. Effects of the experimental chemopreventative agent, glucarate, on intestinal carcinogenesis in rats.
Dwivedi C; Oredipe OA; Barth RF; Downie AA; Webb TE
Carcinogenesis; 1989 Aug; 10(8):1539-41. PubMed ID: 2752528
[TBL] [Abstract][Full Text] [Related]
13. Relative efficacy of glucarate on the initiation and promotion phases of rat mammary carcinogenesis.
Abou-Issa H; Moeschberger M; el-Masry W; Tejwani S; Curley RW; Webb TE
Anticancer Res; 1995; 15(3):805-10. PubMed ID: 7645962
[TBL] [Abstract][Full Text] [Related]
14. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen.
Anzano MA; Byers SW; Smith JM; Peer CW; Mullen LT; Brown CC; Roberts AB; Sporn MB
Cancer Res; 1994 Sep; 54(17):4614-7. PubMed ID: 8062253
[TBL] [Abstract][Full Text] [Related]
15. Growth suppression of human breast carcinoma cells in culture by N-(4-hydroxyphenyl)retinamide and its glucuronide and through synergism with glucarate.
Bhatnagar R; Abou-Issa H; Curley RW; Koolemans-Beynen A; Moeschberger ML; Webb TE
Biochem Pharmacol; 1991 May; 41(10):1471-7. PubMed ID: 1826840
[TBL] [Abstract][Full Text] [Related]
16. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
Mehta RG; Williamson E; Patel MK; Koeffler HP
J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
[TBL] [Abstract][Full Text] [Related]
17. [Interaction of interferon with retinoic acid].
Widschwendter M; Daxenbichler G; Marth C; Dapunt O
Gynakol Geburtshilfliche Rundsch; 1994; 34(3):168-70. PubMed ID: 7987085
[TBL] [Abstract][Full Text] [Related]
18. Chemopreventative activity of dietary glucarate on azoxymethane-induced altered hepatic foci in rats.
Oredipe OA; Barth RF; Dwivedi C; Webb TE
Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):345-59. PubMed ID: 2479062
[TBL] [Abstract][Full Text] [Related]
19. Modulation of chemically initiated and promoted skin tumorigenesis in CD-1 mice by dietary glucarate.
Dwivedi C; Downie AA; Webb TE
J Environ Pathol Toxicol Oncol; 1989; 9(3):253-9. PubMed ID: 2509679
[TBL] [Abstract][Full Text] [Related]
20. Melatonin synergizes with retinoic acid in the prevention and regression of breast cancer.
Hill SM; Teplitzky S; Ram PT; Kiefer T; Blask DE; Spriggs LL; Eck KM
Adv Exp Med Biol; 1999; 460():345-62. PubMed ID: 10810532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
